Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 6
2006 2
2007 2
2008 2
2009 3
2010 3
2011 3
2012 6
2013 9
2014 11
2015 8
2016 8
2017 8
2018 13
2019 17
2020 25
2021 21
2022 25
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
Zhou X, Jiang Y, Wang Y, Fan L, Zhu Y, Chen Y, Wang Y, Zhu Y, Wang H, Pan Z, Li Z, Zhu X, Ren R, Ge Z, Lai D, Lai EY, Chen T, Wang K, Liang P, Qin L, Liu C, Qiu C, Simons M, Yu L. Zhou X, et al. Circ Res. 2023 Sep;133(6):508-531. doi: 10.1161/CIRCRESAHA.122.321200. Epub 2023 Aug 17. Circ Res. 2023. PMID: 37589160
FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis.
Zhu X, Qiu C, Wang Y, Jiang Y, Chen Y, Fan L, Ren R, Wang Y, Chen Y, Feng Y, Zhou X, Zhu Y, Ge Z, Lai D, Qin L, Simons M, Yu L. Zhu X, et al. Among authors: zhou x. Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2202631119. doi: 10.1073/pnas.2202631119. Epub 2022 Jun 21. Proc Natl Acad Sci U S A. 2022. PMID: 35733256 Free PMC article.
Targeting ubiquitin signaling for cancer immunotherapy.
Zhou X, Sun SC. Zhou X, et al. Signal Transduct Target Ther. 2021 Jan 13;6(1):16. doi: 10.1038/s41392-020-00421-2. Signal Transduct Target Ther. 2021. PMID: 33436547 Free PMC article. Review.
Lung inflammation perturbation by engineered nanoparticles.
Zhou X, Jin W, Ma J. Zhou X, et al. Front Bioeng Biotechnol. 2023 May 25;11:1199230. doi: 10.3389/fbioe.2023.1199230. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37304133 Free PMC article. Review.
NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.
Gu M, Zhou X, Sohn JH, Zhu L, Jie Z, Yang JY, Zheng X, Xie X, Yang J, Shi Y, Brightbill HD, Kim JB, Wang J, Cheng X, Sun SC. Gu M, et al. Among authors: zhou x. Nat Immunol. 2021 Feb;22(2):193-204. doi: 10.1038/s41590-020-00829-6. Epub 2021 Jan 4. Nat Immunol. 2021. PMID: 33398181 Free PMC article.
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
Rodriguez BL, Chen L, Li Y, Miao S, Peng DH, Fradette JJ, Diao L, Konen JM, Alvarez FRR, Solis LM, Yi X, Padhye A, Gibson LA, Ochieng JK, Zhou X, Wang J, Gibbons DL. Rodriguez BL, et al. Among authors: zhou x. Front Immunol. 2023 Jun 28;14:1161869. doi: 10.3389/fimmu.2023.1161869. eCollection 2023. Front Immunol. 2023. PMID: 37449205 Free PMC article.
171 results